litlas
Log inCreate account

Robert J. Mayer

Active 1963–2024

175
Papers
46,393
Citations
109
h-index
173
i10-index

Citations

Citations per year for Robert J. Mayer1974: 1 citations1975: 5 citations1976: 3 citations1978: 4 citations1979: 4 citations1980: 2 citations1981: 8 citations1982: 11 citations1983: 10 citations1984: 20 citations1985: 19 citations1986: 14 citations1987: 17 citations1988: 10 citations1989: 12 citations1990: 15 citations1991: 26 citations1992: 17 citations1993: 22 citations1994: 30 citations1995: 40 citations1996: 47 citations1997: 81 citations1998: 54 citations1999: 96 citations2000: 98 citations2001: 130 citations2002: 174 citations2003: 184 citations2004: 238 citations2005: 386 citations2006: 382 citations2007: 414 citations2008: 425 citations2009: 430 citations2010: 417 citations2011: 413 citations2012: 361 citations2013: 343 citations2014: 322 citations2015: 305 citations2016: 259 citations2017: 286 citations2018: 221 citations2019: 989 citations2020: 947 citations2021: 825 citations2022: 606 citations2023: 398 citations2024: 651 citations2025: 298 citations2026: 5 citations1977: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,292 citing papers, 30.6% of this breakdownChina: 1,176 citing papers, 8.4% of this breakdownUnited Kingdom: 832 citing papers, 5.9% of this breakdownItaly: 791 citing papers, 5.6% of this breakdownGermany: 782 citing papers, 5.6% of this breakdownFrance: 580 citing papers, 4.1% of this breakdownJapan: 573 citing papers, 4.1% of this breakdownCanada: 513 citing papers, 3.6% of this breakdownNetherlands: 472 citing papers, 3.4% of this breakdownSpain: 432 citing papers, 3.1% of this breakdownAustralia: 348 citing papers, 2.5% of this breakdownSouth Korea: 259 citing papers, 1.8% of this breakdown
0%30.6%Other 21.3%

Institutions

Fields

  • Medicine76.1%
  • Biochemistry, Genetics and Molecular Biology18.5%
  • Immunology and Microbiology1.2%
  • Health Professions0.5%
  • Materials Science0.4%
  • Physics and Astronomy0.4%
  • Other2.9%

Topics

  • Colorectal Cancer Treatments and Studies7%
  • Colorectal Cancer Surgical Treatments4.5%
  • Genetic factors in colorectal cancer4.3%
  • Colorectal Cancer Screening and Detection3.3%
  • Gastric Cancer Management and Outcomes2.9%
  • Pancreatic and Hepatic Oncology Research2.8%
  • Other75.2%

Coauthors

All papers

Open in search
  1. Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    Authors: Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio García‐Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu, Alberto Sobrero, Éveline Boucher, Marc Peeters, Ben Tran, Heinz‐Josef Lenz, Alberto Zaniboni, Howard S. Höchster, James M. Cleary, Hans Prenen, Fabio Benedetti, Hirokazu Mizuguchi, Lukas Makris, Masanobu Ito, Atsushi Ohtsu - New England Journal of Medicine 2015 cited by 1,431

  2. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

    Authors: Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, Claire Greene, Bert H. O’Neil, James N. Atkins, Scott Berry, Blasé N. Polite, Eileen M. O’Reilly, Richard M. Goldberg, Howard S. Höchster, Richard L. Schilsky, Monica M. Bertagnolli, Anthony B. El-Khoueiry, Peter J. Watson, Al B. Benson, Daniel Mulkerin, Robert J. Mayer, Charles D. Blanke - JAMA 2017 cited by 893

  3. Esophageal Cancer

    Authors: Peter C. Enzinger, Robert J. Mayer - New England Journal of Medicine 2003 cited by 2,517

  4. Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine

    Authors: Andrew J. Aguirre, Jonathan A. Nowak, Nicholas D. Camarda, Richard A. Moffitt, Arezou A. Ghazani, Mehlika Hazar-Rethinam, Srivatsan Raghavan, Jaegil Kim, Lauren K. Brais, Dorisanne Ragon, Marisa W. Welch, Emma Reilly, Devin McCabe, Lori Marini, Kristin Anderka, Karla Helvie, Nelly Oliver, Ana Babić, Annacarolina da Silva, Brandon Nadres, Emily E. Van Seventer, Heather A. Shahzade, Joseph P. St. Pierre, Kelly P. Burke, Thomas E. Clancy, James M. Cleary, Leona A. Doyle, Kunal Jajoo, Nadine J. McCleary, Jeffrey A. Meyerhardt, Janet E. Murphy, Kimmie Ng, Anuj Patel, Kimberly Perez, Michael H. Rosenthal, Douglas A. Rubinson, Marvin Ryou, Geoffrey I. Shapiro, Ewa Sicińska, Stuart G. Silverman, Rebecca J. Nagy, Richard B. Lanman, Deborah Knoerzer, Dean J. Welsch, Matthew B. Yurgelun, Charles S. Fuchs, Levi A. Garraway, Gad Getz, Jason L. Hornick, Bruce E. Johnson, Matthew H. Kulke, Robert J. Mayer, Jeffrey W. Miller, Paul B. Shyn, David A. Tuveson, Nikhil Wagle, Jen Jen Yeh, William C. Hahn, Ryan B. Corcoran, Scott L. Carter, Brian M. Wolpin - Cancer Discovery 2018 cited by 369

  5. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer

    Authors: Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Brian Allen, Hajime Uno, Jason L. Hornick, Chinedu Ukaegbu, Lauren K. Brais, Philip G. McNamara, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, John Kidd, Nanda Singh, Anne‐Renee Hartman, Richard Wenstrup, Sapna Syngal - Journal of Clinical Oncology 2017 cited by 519

  6. Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)

    Authors: Heinz‐Josef Lenz, Fang‐Shu Ou, Alan P. Venook, Howard S. Höchster, Donna Niedzwiecki, Richard M. Goldberg, Robert J. Mayer, Monica M. Bertagnolli, Charles D. Blanke, Tyler Zemla, Xueping Qu, Pratyaksha Wirapati, Sabine Tejpar, Federico Innocenti, Omar Kabbarah - Journal of Clinical Oncology 2019 cited by 253

  7. Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis

    Authors: Erin L. Van Blarigan, Charles S. Fuchs, Donna Niedzwiecki, Sui Zhang, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, Renaud Whittom, Alexander Hantel, Al B. Benson, Daniel Atienza, Michael J. Messino, Hedy L. Kindler, Alan P. Venook, Shuji Ogino, Edward L. Giovannucci, Kimmie Ng, Jeffrey A. Meyerhardt - JAMA Oncology 2018 cited by 209

  8. Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

    Authors: Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis, Susan Sutherland, Deborah Schrag, Herbert I. Hurwitz, Federico Innocenti, Mary F. Mulcahy, Eileen M. O’Reilly, Timothy F. Wozniak, Joel Picus, Pankaj Bhargava, Robert J. Mayer, Richard L. Schilsky, Richard M. Goldberg - Journal of Clinical Oncology 2010 cited by 842

  9. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019

    Authors: Samir Gupta, Dawn Provenzale, Xavier Llor, Amy L. Halverson, William M. Grady, Daniel C. Chung, Sigurdís Haraldsdóttir, Arnold J. Markowitz, Thomas P. Slavin, Heather Hampel, CGC, Reid M. Ness, Jennifer M. Weiss, Dennis J. Ahnen, Lee-may Chen, Gregory S. Cooper, Dayna S. Early, Francis M. Giardiello, Michael J. Hall, Stanley R. Hamilton, Priyanka Kanth, Jason Klapman, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, June Mikkelson, CGC, Shajan Peter, Scott E. Regenbogen, Mary A. Dwyer, CGC, Ndiya Ogba - Journal of the National Comprehensive Cancer Network 2019 cited by 341

  10. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020

    Authors: Dawn Provenzale, Reid M. Ness, Xavier Llor, Jennifer M. Weiss, Benjamin Abbadessa, Gregory S. Cooper, Dayna S. Early, Mark Friedman, Francis M. Giardiello, Kathryn Glaser, Suryakanth Gurudu, Amy L. Halverson, Rachel B. Issaka, Rishi Jain, Priyanka Kanth, Trilokesh D. Kidambi, Audrey J. Lazenby, Lillias H. Maguire, Arnold J. Markowitz, Folasade P. May, Robert J. Mayer, Shivan J. Mehta, Swati Patel, Shajan Peter, Peter P. Stanich, Jonathan P. Terdiman, Jennifer Keller, Mary A. Dwyer, Ndiya Ogba - Journal of the National Comprehensive Cancer Network 2020 cited by 186

  11. Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

    Authors: Jeffrey A. Meyerhardt, Denise Heseltine, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, James P. Thomas, Heidi Nelson, Renaud Whittom, Alexander Hantel, Richard L. Schilsky, Charles S. Fuchs - Journal of Clinical Oncology 2006 cited by 758

  12. Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089

    Authors: Thomas E. Le Voyer, Elin R. Sigurdson, Alexandra L. Hanlon, Robert J. Mayer, J. S. Macdonald, Paul J. Catalano, Daniel G. Haller - Journal of Clinical Oncology 2003 cited by 1,159

  13. Systemic Therapy for Colorectal Cancer

    Authors: Jeffrey A. Meyerhardt, Robert J. Mayer - New England Journal of Medicine 2005 cited by 1,052

  14. Metal-Pyridoxal Cooperativity in Nonenzymatic Transamination

    Authors: Quentin Dherbassy, Robert J. Mayer, Kamila B. Muchowska, Joseph Moran - Journal of the American Chemical Society 2023 cited by 39

  15. Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

    Authors: Joel E. Tepper, Mark J. Krasna, Donna Niedzwiecki, Donna Hollis, Carolyn E. Reed, Richard M. Goldberg, Krystyna Kiel, Christopher G. Willett, David J. Sugarbaker, Robert J. Mayer - Journal of Clinical Oncology 2008 cited by 1,358

  16. Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

    Authors: Leonard L. Gunderson, Kathryn Winter, Jaffer A. Ajani, John E. Pedersen, Jennifer Moughan, Al B. Benson, Charles R. Thomas, Robert J. Mayer, Michael G. Haddock, Tyvin A. Rich, Christopher G. Willett - Journal of Clinical Oncology 2012 cited by 587

  17. Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer

    Authors: Jeffrey A. Meyerhardt, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Frank B. Hu, Robert J. Mayer, Heidi Nelson, Renaud Whittom, Alexander Hantel, James P. Thomas, Charles S. Fuchs - JAMA 2007 cited by 439

  18. Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

    Authors: Robert J. Mayer, Roger B. Davis, Charles A. Schiffer, Deborah Berg, Bayard L. Powell, Philip Schulman, George Omura, Joseph O. Moore, O. Ross McIntyre, E Frei - New England Journal of Medicine 1994 cited by 1,433

  19. Diet- and Lifestyle‐Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance)

    Authors: En Cheng, Fang‐Shu Ou, Chao Ma, Donna Spiegelman, Sui Zhang, Xin Zhou, Tiffany M. Bainter, Leonard B. Saltz, Donna Niedzwiecki, Robert J. Mayer, Renaud Whittom, Alexander Hantel, Al B. Benson, Daniel Atienza, Michael J. Messino, Hedy L. Kindler, Edward L. Giovannucci, Erin L. Van Blarigan, Justin C. Brown, Kimmie Ng, Cary P. Gross, Jeffrey A. Meyerhardt, Charles S. Fuchs - Journal of Clinical Oncology 2022 cited by 42

  20. Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer

    Authors: Christopher Mackintosh, Chen Yuan, Fang‐Shu Ou, Sui Zhang, Donna Niedzwiecki, I-Wen Chang, Bert H. O’Neil, Brian C Mullen, Heinz‐Josef Lenz, Charles D. Blanke, Alan P. Venook, Robert J. Mayer, Charles S. Fuchs, Federico Innocenti, Andrew B. Nixon, Richard M. Goldberg, Eileen M. O’Reilly, Jeffrey A. Meyerhardt, Kimmie Ng - JAMA Oncology 2020 cited by 49

  21. Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

    Authors: Leonard B. Saltz, Neal J. Meropol, Patrick J. Loehrer, Michael N. Needle, Justin Kopit, Robert J. Mayer - Journal of Clinical Oncology 2004 cited by 1,703

  22. Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

    Authors: Guido Marcucci, Krzysztof Mrózek, Amy S. Ruppert, Kati Maharry, Jonathan E. Kolitz, Joseph O. Moore, Robert J. Mayer, Mark J. Pettenati, Bayard L. Powell, Colin G. Edwards, Lisa J. Sterling, James W. Vardiman, Charles A. Schiffer, Andrew J. Carroll, Richard A. Larson, Clara D. Bloomfield - Journal of Clinical Oncology 2005 cited by 384

  23. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies

    Authors: David E. E. Sloane, Usha Govindarajulu, Jacob Harrow-Mortelliti, William T. Barry, Florence Ida Hsu, David I. Hong, Tanya M. Laidlaw, Ross I. Palis, Henry J. Legere, Supinda Bunyavanich, Rebecca G. Breslow, Duane R. Wesemann, Nora A. Barrett, Patrick J. Brennan, Hey Chong, Anne Liu, James Fernandez, Laura B. Fanning, Timothy Kyin, Katherine N. Cahill, Lora G. Bankova, Ashly Lynch, Suzanne Berlin, Susana M. Campos, Charles S. Fuchs, Robert J. Mayer, Ursula A. Matulonis, Mariana Castells - The Journal of Allergy and Clinical Immunology In Practice 2016 cited by 207

  24. Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes

    Authors: Adam C. Berger, Elin R. Sigurdson, Thomas E. LeVoyer, Alexandra L. Hanlon, Robert J. Mayer, John S. Macdonald, Paul J. Catalano, Daniel G. Haller - Journal of Clinical Oncology 2005 cited by 517